Active

Nissan Chemical seeks startups and researchers to develop applications for novel spheroid and organoid mass production systems

Deadline: May 13, 2021

Nissan Chemical Corporation has combined its unparalleled expertise in precision organic synthesis, polymer design, nano-particle technology and biological evaluation to develop game-changing innovations. Our solutions benefit regenerative medicine development, drug discovery and several other life sciences industries.

We are developing new manufacturing systems of large quantities of cell spheroids for regenerative medicines and drug discoveries and are now seeking potential collaborators for development of new applications of this system.

Characteristics of our system:

  • Flat Sheets to make spheroids spontaneously:
    • Can control size and shape of spheroid
    • Harvesting uniform size of spheroids (better than micro-well plate system)
    • Developing clinical grade

Potential Collaborators:

  • Startups and researchers that use spheroids and organoids for regenerative medicine development:
    • Startups and researchers that use spheroids and organoids for drug discovery
    • Startups or CMOs that develop mass manufacturing methods of spheroids
Deadline: May 13, 2021
Posted on: April 14, 2021
Location: E-meeting (WebEx, Skype, Zoom, etc.)

Nissan Chemical Corporation has combined its unparalleled expertise in precision organic synthesis, polymer design, nano-particle technology and biological evaluation to develop game-changing innovations. Our solutions benefit regenerative medicine development, drug discovery and several other life sciences industries.

We are developing new manufacturing systems of large quantities of cell spheroids for regenerative medicines and drug discoveries and are now seeking potential collaborators for development of new applications of this system.

Characteristics of our system:

  • Flat Sheets to make spheroids spontaneously:
    • Can control size and shape of spheroid
    • Harvesting uniform size of spheroids (better than micro-well plate system)
    • Developing clinical grade

Potential Collaborators:

  • Startups and researchers that use spheroids and organoids for regenerative medicine development:
    • Startups and researchers that use spheroids and organoids for drug discovery
    • Startups or CMOs that develop mass manufacturing methods of spheroids

Application Requirements

In your response, please

  • Concisely what you offer & your match with the company above and their interest
  • Any relevant cases / customer stories (can indicate industry/size if not ready to go public)
  • Application Requirements

    In your response, please

    • Concisely what you offer & your match with the company above and their interest
    • Any relevant cases / customer stories (can indicate industry/size if not ready to go public)

Disclaimer:  MIT Startup Exchange provides introductions that ideally provides open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which take no responsibility for the outcome of such discussions and takes no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.